Authors
Latest:
Secondary Smoke Is Dangerous to Asthmatic ChildrenMs. Norwalt is a 2008 PharmD candidate and Dr. Isaac is a clinical assistant professor of pharmacy at Xavier University of Louisiana College of Pharmacy, New Orleans.
Latest:
E-Prescribing With Decision Support Is Associated With Improvements in Medication AdherenceThis study evaluates whether provider adoption and use of formulary decision support for e-prescribing are directly associated with significant prescriber and patient behavior change.
Latest:
Ten Tips to Help Your Patients Increase Fertility NaturallyHow specialty pharmacies can improve the treatment success of women receiving in-vitro fertilization.
Latest:
Financial Accruals in the Specialty Pharmaceutical Industry: The Case for Automating the ProcessAs payers and providers are required to provide real-world outcomes data, there is high demand for the detailed financial reporting that an automated financial accruals process can produce. Here's what stakeholders need to know about the process.
Latest:
The Changing Landscape of Breast Cancer TreatmentSeveral chemotherapy agents have been investigated for neoadjuvant use in HER2-positive breast cancer.
Latest:
Catalyzing Change: Educating Healthcare Stakeholders on Pharmacist Care ProgramsA multistakeholder, statewide symposium demonstrated the value of innovative pharmacist-led patient care programs and generated 9 key measures for planning or examining such programs.
Latest:
Mental Health First Aid as a Skill Set for Community Pharmacy PersonnelMental illness affects tens of millions of people in the United States each year. However, overall, only about half of those affected receive treatment.
Latest:
Community-Acquired Pneumonia: Opportunities for Generalist Stewardship PharmacistsCommunity-acquired pneumonia is a common infection and a leading cause of morbidity and mortality worldwide.
Latest:
Cost of Squamous Cell Cancer of the Head and NeckThe cost of squamous cell cancer of the head and neck is driven primarily by the end-of-life phase. Treatment costs increased following the approval of cetuximab.
Latest:
SBRT Improves Options for Prostate CancerFor some patients, stereotactic body radiation therapy may provide an enhanced quality of life, better efficacy, and reduced adverse effects.
Latest:
Terlipressin Has Been Shown to Improve HRS Reversal Outcomes, but Concerns RemainThe drug is the first FDA-approved agent for treating hepatorenal syndrome.
Latest:
Federal Officials Push for Fair Medicaid ReimbursementAs a vote on the final health care reform bill draws nearer, 16 representatives and 9 senators are pushing for what they consider fair Medicaid reimbursement for generic drugs.
Latest:
Prefilled Syringe Vaccine Doses: An Emerging Option in the Retail-Based Clinic SettingPrefilled syringe use offers advantages that can help pharmacists improve quality of care.
Latest:
Case StudiesCase studies involving patients with influenza or in close proximity to patients with influenza.
Latest:
COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy PerspectiveThe increasing prevalence of oral oncolytics use, further accelerated by COVID-19, heightens the need for strong patient-pharmacist treatment coordination.
Latest:
Offer Patients Counseling on ADFsPharmacists can extend education to prescribers and provide important guidance on abuse-deterrent opioid formulations.
Latest:
Which Drug Interactions Matter in Older Adults?Polypharmacy is often a factor in the adverse events that elders experience.
Latest:
Do Units and Costs of Comparable Insulins Differ by Manufacturer?Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.
Latest:
Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US PayersAn examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
Latest:
Technicians Can Help With Sterile CompoundingAmid pharmacy strikes and ongoing challenges, technicians can identify new opportunities for growth
Latest:
DAURISMO for Acute Myeloid LeukemiaOn November 2018, the FDA approved Pfizer’s glasdegib (Daurismo) for the treatment of newly diagnosed acute myeloid leukemia (AML) in patients 75 years and older with comorbidities that prevent the use of intensive induction-dose chemotherapy.
Latest:
Old Drugs Are New AgainUnique formulations, new indications, and the 'rediscovery' of already approved drugs are just a few of the innovations pharmacists can expect as drug makers revitalize their product portfolios.
Latest:
PREP Act Provides Opportunities for Advanced RolesCan the profession afford not to retain expanded job roles for technicians in a post-pandemic era?
